Clinical Trial Update: Effect of Different Dosage of Umbilical Cord-mesenchymal Stem Cells Through Peripheral Vein in Patients With ESLD [NA]

View source ↗

Summary

This clinical trial evaluates different dosages of umbilical cord-derived mesenchymal stem cells delivered through the peripheral vein in patients with end-stag…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease

Drugs mentioned

• Umbilical cord-derived mesenchymal stem cells (mesenchymal stem cells)

Snippet

Sponsor: General Hospital of Shenyang Military Region | Conditions: End-stage Liver Diseases | NA | Status: COMPLETED